nach oben

Journal of Clinical Immunology

Erschienen in:

01.09.2008 | Original Paper

Use of Sirolimus in IPEX and IPEX-Like Children

verfasst von: Pierre L. Yong, Pierre Russo, Kathleen E. Sullivan

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

IPEX (immune dysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome), a rare inflammatory disease caused by mutations of Foxp3, destroys the immunoregulatory environment of affected male infants. Data on optimal therapy are limited.

Methods

We reviewed the effect of sirolimus use in our cohort of IPEX and IPEX-like patients (n = 7).

Results and Discussion

Our patients exhibited features of enteropathy and recurrent infections with bacterial and viral pathogens. Before initiating sirolimus, six patients were treated with corticosteroids. Several also received other immunosuppressive agents. After starting sirolimus, six patients had improvement in diarrhea, and two were able to decrease corticosteroid dosages. Several also had significantly decreased number of infections after treatment. Of the three patients with post-treatment duodenal biopsies, two showed improvement in villous architecture. No significant adverse events occurred. Our experience suggests that sirolimus is a clinically effective and safe therapeutic option in IPEX and IPEX-like patients.

Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–1.PubMedCrossRef

Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J All Clin Immunol. 2007;120:744–50.CrossRef

Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol. 2007;119:482–7.PubMedCrossRef

Baud O, Goulet O, Canioni D, LeDeist F, Radford I, Rieu D, et al. Treatment of IPEX by allogeneic BMT. NEJM. 2001;344:1758–62.PubMedCrossRef

Mazzolari E, Forino C, Fontana M, Ippolito CD, Lanfranchi A, Gambineri E, Ochs H, Badolato R, Notarangelo LD. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant. 2005;35:1033–4.PubMedCrossRef

Rao A, Kamani N, Filipovich A, Lee SM, Davies SM, Dalal J, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood. 2007;109(1):383–5.PubMedCrossRef

Powell BR, Buist NRM, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr. 1982;100:731–7.PubMedCrossRef

DiRocco M, Marta R. X-linked immune deregulation, neonatal insulin-dependent diabetes, and intractable diarrhoea. Arch Dis Child. 1996;75:F143.

Ellis D, Fisher SE, Smith WI, Jaffe R. Familial occurrence of renal and interstitial disease associated with tissue autoantibodies. Am J Dis Child. 1982;136:323–6.PubMed

10.

Peake JE, McCrossin RB, Byrne G, Shepherd R. X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch Dis Child. 1996;74:F195–9.CrossRef

11.

Mirakian R, Richardson A, Milla PJ, Walker-Smith JA, Unsworth J, Savage MO, et al. Protracted diarrhoea of infancy: evidence in support of an autoimmune variant. BMJ. 1986;293:1132–6.PubMed

12.

Savage MO, Mirakian R, Harries JT, Bottazzo GF. Could protracted diarhoea of infancy have an autoimmune pathogenesis? Lancet. 1982;i:966–7.CrossRef

13.

Walker-Smith JA, Unsworth DJ, Hutchins P, Phillips AD, Holborow EJ. Autoantibodies against gut epithelium in child with small-intestinal enteropathy. Lancet. 1982;i:566–7.CrossRef

14.

Ferguson PJ, Blanton SH, Saulsbury FT, McDuffie MJ, Lemahieu V, Gastier JM, et al. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Gen. 2000;90:390–7.CrossRef

15.

Levy-Lahad E, Wildin RS. Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: further evidence for an X-linked lethal syndrome. J Pediatr. 2001;138:577–80.PubMedCrossRef

16.

Bousvaros A, Leichtner AM, Book L, Shigeoka A, Bilodeau J, Semeao E, et al. Treatment of pediatric autoimmune enteropathy with tacrolimus. Gastroenterology. 1996;111:237–43.PubMedCrossRef

17.

Kobayashi I, Nakanishi M, Okano M, Sakiyama Y, Matsumoto S. Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. Eur J Pediatr. 1995;154:594–5.PubMedCrossRef

18.

Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the IPEX syndrome. J Med Genet. 2002;39:537–45.PubMedCrossRef

19.

Napoli KL, Taylor PJ. From beach to bedside: history of the development of sirolimus. Ther Drug Monit. 2001;23:559–86.PubMedCrossRef

20.

Sousa JE, Costa MA, Sousa AGMR, Abizaid AC, Seixas AC, Abizid AS, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 2003;107:381–3.PubMedCrossRef

21.

Battaglia M, Stabilini A, Migliavacca B, Jorejs-Joeck J, Kaupper T, Roncarolol MG. Rapamycin promotes expansion of function CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol. 2006;177:8338–47.PubMed

22.

Coenen JJA, Koenin HJPM, van Rijssen E, Kasran A, Boon L, Hilbrandds LB, et al. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+CD25+FoxP3+ T cells. Bone Marrow Transplant. 2007;39:537–45.PubMedCrossRef

23.

Bindl L, Torgerson T, Perroni L, Youssef N, Ochs HD, Goulet O, et al. Successful use of the new immune-suppressor sirolimus in IPEX. J Pediatr. 2005;147:256–9.PubMedCrossRef

24.

Owen CJ, Jenings CE, Imrie H, Lachaux A, Bridges NA, Cheetham TD, et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab. 2003;88:6034–9.PubMedCrossRef

Titel: Use of Sirolimus in IPEX and IPEX-Like Children
verfasst von: Pierre L. Yong
Pierre Russo
Kathleen E. Sullivan
Publikationsdatum: 01.09.2008
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 5/2008
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-008-9196-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Use of Sirolimus in IPEX and IPEX-Like Children

Abstract

Introduction

Methods

Results and Discussion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Introduction

Methods

Results and Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2008

Single Nucleotide Polymorphism in DNMT3B Promoter and the Risk for Idiopathic Thrombocytopenic Purpura in Chinese Population

Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways

Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells

Genetic Polymorphisms in the CD40 Ligand Gene and Kawasaki Disease

Impact of Three Anti-TNFα Biologics on Existing and Emergent Autoimmunity in Rheumatoid Arthritis and Spondylarthropathy Patients

IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin